Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Metformin’S Therapeutic Potential in Spinal Cord Injury: A Systematic Review and Meta-Analysis on Locomotor Recovery, Neuropathic Pain Alleviation, and Modulation of Secondary Injury Mechanisms Publisher Pubmed



Vazirizadehmahabadi M1 ; Azimi A2 ; Yarahmadi M2 ; Zarei H2 ; Tahmasbi F3 ; Zarrin A2 ; Yousefifard M2 ; Rahimimovaghar V4
Authors
Show Affiliations
Authors Affiliations
  1. 1. Men’s Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  2. 2. Physiology Research Center, Iran University of Medical Sciences, Tehran, Iran
  3. 3. Emergency and Trauma Care Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  4. 4. Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Acta Neurochirurgica Published:2025


Abstract

Objective: To evaluate metformin’s efficacy in locomotion recovery, alleviating neuropathic pain, and modulating underlying molecular mechanisms in Spinal Cord Injury (SCI) rodent models through a systematic review and meta-analysis. Methods: We conducted a comprehensive literature search across Medline, Embase, Scopus, and Web of Science from inception to May 2024. We included studies that utilized rodent models of traumatic SCI treated with metformin versus untreated controls. Data on locomotor recovery, neuropathic pain, and molecular mechanisms related to secondary injury were extracted. Standardized mean differences (SMDs) were synthesized as the pooled effect sizes. Results: Twenty-three studies comprising 1,567 animals met the inclusion criteria. Metformin significantly enhanced locomotor function (SMD = 2.23, 95% CI: 1.74, 2.73, p < 0.001) and improved both mechanical allodynia (SMD = 1.18; 95% CI, 0.35 to 2.00; p = 0.005) and thermal hyperalgesia (SMD = 2.40; 95% CI, 1.65 to 3.16; p < 0.001). It reduces inflammation, oxidative stress, microglial activation, and astrogliosis and promotes myelination and autophagy flux via activating the adenosine monophosphate-activated protein kinase (AMPK) signaling pathway. This resulted in decreased apoptosis and lesion size and increased tissue preservation and neuronal survival. Subgroup analyses indicated greater locomotor improvements when metformin was administered in the acute (< 3 days of injury) phase of the injury (meta-regression coefficient = 1.65; 95% CI, 0.37 to 2.93; p = 0.011). Conclusion: Metformin shows significant therapeutic benefits for SCI in rodent models, promoting locomotor recovery and alleviating neuropathic pain. These results underscore its translational potential for clinical SCI management. © The Author(s) 2025.
Related Docs
View other Related Docs
1. Anti-Inflammatory Effects of Metformin Improve the Neuropathic Pain and Locomotor Activity in Spinal Cord Injured Rats: Introduction of an Alternative Therapy, Spinal Cord (2018)
2. Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next?, ACS Pharmacology and Translational Science (2021)
3. Inhibition of Phosphodiesterase Iv Enzyme Improves Locomotor and Sensory Complications of Spinal Cord Injury Via Altering Microglial Activity: Introduction of Roflumilast As an Alternative Therapy, International Immunopharmacology (2020)
4. Sumatriptan Improves the Locomotor Activity and Neuropathic Pain by Modulating Neuroinflammation in Rat Model of Spinal Cord Injury, Neurological Research (2021)
5. Aripiprazole Improves Spinal Cord Injury in Rats: Involvement of Inflammatory Pathways, Acta Medica Iranica (2022)
6. Combined Effects of Rat Schwann Cells and 17Β-Estradiol in a Spinal Cord Injury Model, Metabolic Brain Disease (2018)
7. Facile Fabrication of Selegiline-Loaded Alginate Hydrogel for Neuroprotection and Functional Recovery in a Rat Model of Spinal Cord Injury Through Localized Spinal Delivery, Iranian Journal of Basic Medical Sciences (2025)
8. Epidemiology of Traumatic Spinal Cord Injuries in Iran; a Systematic Review Andmeta-Analysis, Archives of Academic Emergency Medicine (2022)
Experts (# of related papers)
View all Related Experts
Ahmad Reza Dehpour (5)
Seyed Mohammad Tavangar (3)
Other Related Docs
9. Tissue-Engineered Regeneration of Hemisected Spinal Cord Using Human Endometrial Stem Cells, Poly Ε-Caprolactone Scaffolds, and Crocin As a Neuroprotective Agent, Molecular Neurobiology (2017)
10. Acute Transplantation of Human Olfactory Mucosa-Derived Olfactory Ensheathing Cells Fails to Improve Locomotor Recovery in Rats, Acta Medica Iranica (2018)
11. Pcl/Gelatin Nanofibrous Scaffolds With Human Endometrial Stem Cells/Schwann Cells Facilitate Axon Regeneration in Spinal Cord Injury, Journal of Cellular Physiology (2019)
12. Metformin Therapy Attenuates Pro-Inflammatory Microglia by Inhibiting Nf-Κb in Cuprizone Demyelinating Mouse Model of Multiple Sclerosis, Neurotoxicity Research (2021)
13. Efficacy of Some Non-Conventional Herbal Medications (Sulforaphane, Tanshinone Iia, and Tetramethylpyrazine) in Inducing Neuroprotection in Comparison With Interleukin-10 After Spinal Cord Injury: A Meta-Analysis, Journal of Spinal Cord Medicine (2015)
14. Evaluating the Anti-Neuropathic Effects of the Thymol-Loaded Nanofibrous Scaffold in a Rat Model of Spinal Cord Injury, Frontiers in Pharmacology (2025)
15. Molecular Evidence on the Inhibitory Potential of Metformin Against Chlorpyrifos-Induced Neurotoxicity, Toxics (2022)
16. Advanced Approaches to Regenerate Spinal Cord Injury: The Development of Cell and Tissue Engineering Therapy and Combinational Treatments, Biomedicine and Pharmacotherapy (2022)
17. All-Trans Retinoic Acid–Preconditioned Mesenchymal Stem Cells Improve Motor Function and Alleviate Tissue Damage After Spinal Cord Injury by Inhibition of Hmgb1/Nf-Κb/Nlrp3 Pathway Through Autophagy Activation, Journal of Molecular Neuroscience (2022)
18. Novel Therapeutic Approach to Slow Down the Inflammatory Cascade in Acute/Subacute Spinal Cord Injury: Early Immune Therapy With Lipopolysaccharide Enhanced Neuroprotective Effect of Combinational Therapy of Granulocyte Colony-Stimulating Factor and Bone-Marrow Mesenchymal Stem Cell in Spinal Cord Injury, Frontiers in Cellular Neuroscience (2022)